Results 11 to 20 of about 38,224 (238)
Nature BiotechnologyThe purpose of this Special Issue was to host research and review papers on Radiopharmaceuticals in line with the three previous Special Issues that I have Guest Edited for Molecules.
Singh C, Tafti D.
europepmc +8 more sources
Radiopharmaceuticals in cardiology [PDF]
Nuclear Medicine Review, 2012 Myocardial perfusion studies are among the most often performed investigations in Nuclear Medicine. However, the development of radiopharmaceuticals for cardiology is an emerging discipline and several other radiotracers have been proven to be useful.
Renata, Mikołajczak, Piotr, Garnuszek
openaire +4 more sources
Development Strategy for Innovation System of Radiopharmaceuticals in China
中国工程科学, 2022 Nuclear medicine plays an irreplaceable role in the diagnosis, therapy, and prognosis of various diseases. Radiopharmaceuticals are the cornerstone of nuclear medicine; their systematic development could accelerate the innovation and clinical application
Peng Shuming +5 more
doaj +2 more sources
Therapy with Radiopharmaceuticals [PDF]
Acta Oncologica, 2002 In an investigation by the Swedish Cancer Society, an expert group described the present status, critical issues and future aspects and potentials for each of nine major areas of radiation therapy research. The present report deals with therapy with radiopharmaceuticals.
Jörgen, Carlsson +4 more
openaire +3 more sources
Strategies for Innovative Development of Tumor-targeted Theranostic Radiopharmaceuticals [PDF]
Yuanzineng kexue jishuRadiopharmaceutical is an essential component of nuclear medicine and have demonstrated significant potential in disease diagnosis and treatment. In recent years, several tumor-targeted theranostic radiopharmaceuticals have been approved for market ...
HUANG Xuhu1, 2, 3, CHEN Huan1, 2, 3, LI Kexin1, 2, 3, WANG Ning1, 2, 3, ZHUANG Jin1, 2, 3, LI Hongyu1, 2, 3, DU Jin2, 3, 4
doaj +2 more sources
Scientific Reports, 2022 Highest global cancer incidence of female breast cancer is a matter of great concern. HER2-positive breast cancers have high mortality rate hence detection at an early stage is vital for successful treatment, improved cancer care and survival rate ...
Amit Kumar Sharma +6 more
doaj +1 more source
Preparation and Preliminary Imaging of Novel Albumin-Binding PSMA Ligand ［177Lu］Lu-DOTA-CPN-PSMA
He huaxue yu fangshe huaxue, 2023 A novel PSMA targeting molecule ［177Lu］Lu-DOTA-CPN-PSMA with high uptake and long retention in prostate cancer was developed, in which DOTA was used as the bifunctional chelator, glutamic acid-urea-lysine(Glu-Urea-Lys) was used as the targeting group ...
LUO Tian-wei +7 more
doaj +1 more source
EJNMMI Research, 2020 Background The objective of this study was to make a quantitative comparison of flortaucipir PET retention with pathological tau and β-amyloid across a range of brain regions at autopsy.
Michael J. Pontecorvo +21 more
doaj +1 more source
EJNMMI Radiopharmacy and Chemistry, 2021 Background There is a need to develop new and more potent radiofluorinated peptide and their hybrid conjugates for multiple-receptors targeting properties that overexpress on many cancers.
I. Al Jammaz +4 more
doaj +1 more source
Chemical Engineering Journal Advances, 2023 The entry of no-carrier-added (NCA) 177Lu in the arena of clinical nuclear medicine has revolutionized the practice of targeted radionuclide tumor therapy.
Sourav Patra +4 more
doaj +1 more source